PHOENIX -- A recent product review conducted by Consumer Lab, a respected, independent laboratory that evaluates nutritional products, revealed startling findings after testing probiotic supplements (Lactobacillus acidophilus, Bifidobacterium and others). One-third of the products tested contained less than 1 percent of the active bacteria claimed on the label.
Since consumers use probiotics to add beneficial bacteria to their own intestinal flora, these products should supply a sufficient amount of beneficial bacteria in order to be effective. Some probiotics tested claimed to contain billions of units per serving, yet Consumer Lab tests concluded these products contained 10,000 times less bacteria than was indicated on the label. This not only brings into question the benefits of supplementing one's diet with probiotics, but also the faith that consumers are getting what's stated on the bottle.
A common misconception is that probiotics colonize, but this is not the case. Probiotics are simply temporary support for the body's own intestinal flora. However, consumers can easily achieve the same -- and often better -- results by adding soluble fiber prebiotics to their diet. With diets high in refined foods, most of us lack sufficient dietary fiber, which leads to floral imbalance.
"Floral imbalance (intestinal dysbiosis) can impair gastrointestinal health and may manifest in afflictions such as irritable bowel syndrome," said Aftab Ahmed, PhD, vice president of research and development at Marlyn Nutraceuticals.
Research shows soluble prebiotic fiber, derived from Jerusalem artichoke (inulin), feeds and promotes growth of the body's own beneficial intestinal bacteria. By nourishing the flora native to your intestines, your gastrointestinal system becomes healthier and the body's own floral balance is restored. Inulin provides an additional advantage in that the body is able to use minerals and nutrients more efficiently.
Genomic Surveillance A New Frontier in Health Care Outbreak Detection
November 27th 2024According to new research, genomic surveillance is transforming health care-associated infection detection by identifying outbreaks earlier, enabling faster interventions, improving patient outcomes, and reducing costs.
Point-of-Care Engagement in Long-Term Care Decreasing Infections
November 26th 2024Get Well’s digital patient engagement platform decreases hospital-acquired infection rates by 31%, improves patient education, and fosters involvement in personalized care plans through real-time interaction tools.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.